125 related articles for article (PubMed ID: 37772565)
41. Total abdominal colectomy to facilitate complete cytoreduction in 56 patients with mucinous appendiceal neoplasms with peritoneal metastases.
Sugarbaker PH; Chang D
J Surg Oncol; 2023 May; 127(6):1011-1018. PubMed ID: 36785941
[TBL] [Abstract][Full Text] [Related]
42. Incomplete cytoreduction with peritoneal metastases from appendiceal mucinous neoplasms.
Sugarbaker PH; Chang D
J Surg Oncol; 2022 Dec; 126(8):1462-1470. PubMed ID: 36102369
[TBL] [Abstract][Full Text] [Related]
43. Mutational profiles and prognostic impact in colorectal and high-grade appendiceal adenocarcinoma with peritoneal metastases.
Morgan RB; Dhiman A; Sood D; Ong CT; Wu X; Shergill A; Polite B; Turaga KK; Eng OS
J Surg Oncol; 2023 Apr; 127(5):831-840. PubMed ID: 36636792
[TBL] [Abstract][Full Text] [Related]
44. Prognostic features of 51 colorectal and 130 appendiceal cancer patients with peritoneal carcinomatosis treated by cytoreductive surgery and intraperitoneal chemotherapy.
Sugarbaker PH; Jablonski KA
Ann Surg; 1995 Feb; 221(2):124-32. PubMed ID: 7857141
[TBL] [Abstract][Full Text] [Related]
45. Cytoreductive surgery and HIPEC for peritoneal metastases combined with curative treatment of colorectal liver metastases: Systematic review of all literature and meta-analysis of observational studies.
de Cuba EM; Kwakman R; Knol DL; Bonjer HJ; Meijer GA; Te Velde EA
Cancer Treat Rev; 2013 Jun; 39(4):321-7. PubMed ID: 23244778
[TBL] [Abstract][Full Text] [Related]
46. Critical analysis of 33 patients with peritoneal carcinomatosis secondary to colorectal and appendiceal signet ring cell carcinoma.
Chua TC; Pelz JO; Kerscher A; Morris DL; Esquivel J
Ann Surg Oncol; 2009 Oct; 16(10):2765-70. PubMed ID: 19641972
[TBL] [Abstract][Full Text] [Related]
47. Outcomes in Peritoneal Carcinomatosis from Appendiceal Goblet Cell Carcinoma Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (CRS/HIPEC).
Zambrano-Vera K; Sardi A; Munoz-Zuluaga C; Studeman K; Nieroda C; Sittig M; King MC; Sipok A; Gushchin V
Ann Surg Oncol; 2020 Jan; 27(1):179-187. PubMed ID: 31646450
[TBL] [Abstract][Full Text] [Related]
48. Cure for peritoneal metastases? An evidence-based review.
Ung L; Chua TC; Morris DL
ANZ J Surg; 2013 Nov; 83(11):821-6. PubMed ID: 23809063
[TBL] [Abstract][Full Text] [Related]
49. Clinical outcomes of complete cytoreduction with concurrent liver resection followed by hyperthermic intraperitoneal chemotherapy for synchronous peritoneal and liver metastatic colorectal cancer.
Jeon Y; Park EJ; Lim JH; Baik SH
World J Surg Oncol; 2019 Dec; 17(1):214. PubMed ID: 31829188
[TBL] [Abstract][Full Text] [Related]
50. The importance of gender in patients with peritoneal metastases of appendiceal origin treated by cytoreduction and intraperitoneal chemotherapy: an analysis of 257 consecutive patients from an Australian centre.
Ung L; Chua TC; Morris DL
J Cancer Res Clin Oncol; 2014 Jun; 140(6):1037-45. PubMed ID: 24652408
[TBL] [Abstract][Full Text] [Related]
51. Impact of Synchronous Versus Metachronous Onset of Colorectal Peritoneal Metastases on Survival Outcomes After Cytoreductive Surgery (CRS) with Hyperthermic Intraperitoneal Chemotherapy (HIPEC): A Multicenter, Retrospective, Observational Study.
Hentzen JEKR; Rovers KP; Kuipers H; van der Plas WY; Been LB; Hoogwater FJH; van Ginkel RJ; Hemmer PHJ; van Dam GM; de Hingh IHJT; Kruijff S
Ann Surg Oncol; 2019 Jul; 26(7):2210-2221. PubMed ID: 30877495
[TBL] [Abstract][Full Text] [Related]
52. Preoperative Risk Score for Predicting Incomplete Cytoreduction: A 12-Institution Study from the US HIPEC Collaborative.
Zaidi MY; Lee RM; Gamboa AC; Speegle S; Cloyd JM; Kimbrough C; Grotz T; Leiting J; Fournier K; Lee AJ; Dineen S; Dessureault S; Kelly KJ; Kotha NV; Clarke C; Gamblin TC; Patel SH; Lee TC; Hendrix RJ; Lambert L; Ronnekleiv-Kelly S; Pokrzywa C; Blakely AM; Lee B; Johnston FM; Fackche N; Russell MC; Maithel SK; Staley CA
Ann Surg Oncol; 2020 Jan; 27(1):156-164. PubMed ID: 31602579
[TBL] [Abstract][Full Text] [Related]
53. Hyperthermic intraperitoneal chemotherapy + early postoperative intraperitoneal chemotherapy versus hyperthermic intraperitoneal chemotherapy alone: assessment of survival outcomes for colorectal and high-grade appendiceal peritoneal carcinomatosis.
Lam JY; McConnell YJ; Rivard JD; Temple WJ; Mack LA
Am J Surg; 2015 Sep; 210(3):424-30. PubMed ID: 26051744
[TBL] [Abstract][Full Text] [Related]
54. Prospective morbidity and mortality assessment of cytoreductive surgery plus perioperative intraperitoneal chemotherapy to treat peritoneal dissemination of appendiceal mucinous malignancy.
Sugarbaker PH; Alderman R; Edwards G; Marquardt CE; Gushchin V; Esquivel J; Chang D
Ann Surg Oncol; 2006 May; 13(5):635-44. PubMed ID: 16523363
[TBL] [Abstract][Full Text] [Related]
55. CA 19-9 to peritoneal carcinomatosis index (PCI) ratio is prognostic in patients with epithelial appendiceal mucinous neoplasms and peritoneal dissemination undergoing cytoreduction surgery and intraperitoneal chemotherapy: A retrospective cohort study.
Kozman MA; Fisher OM; Rebolledo BJ; Valle SJ; Alzahrani N; Liauw W; Morris DL
Eur J Surg Oncol; 2017 Dec; 43(12):2299-2307. PubMed ID: 28993033
[TBL] [Abstract][Full Text] [Related]
56. Total abdominal colectomy, pelvic peritonectomy, and end-ileostomy for the surgical palliation of mucinous peritoneal carcinomatosis from non-gynecologic cancer.
Stamou KM; Karakozis S; Sugarbaker PH
J Surg Oncol; 2003 Aug; 83(4):197-203. PubMed ID: 12884230
[TBL] [Abstract][Full Text] [Related]
57. Secondary cytoreductive surgery and peri-operative intraperitoneal chemotherapy for peritoneal recurrence of colorectal and appendiceal peritoneal carcinomatosis following prior primary cytoreduction.
Klaver YL; Chua TC; Verwaal VJ; de Hingh IH; Morris DL
J Surg Oncol; 2013 May; 107(6):585-90. PubMed ID: 23280508
[TBL] [Abstract][Full Text] [Related]
58. The impact of HIPEC
Leiting JL; Day CN; Harmsen WS; Cloyd JM; Abdel-Misih S; Fournier K; Lee AJ; Dineen S; Dessureault S; Veerapongh J; Baumgartner JM; Clarke C; Mogal H; Russell MC; Zaidi MY; Patel SH; Morris MC; Hendrix RJ; Lambert LA; Abbott DE; Pokrzywa C; Raoof M; Eng O; Johnston FM; Greer J; Grotz TE
Int J Hyperthermia; 2020; 37(1):1182-1188. PubMed ID: 33040617
[TBL] [Abstract][Full Text] [Related]
59. Outcomes in cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for maximal volume (PCI 39) appendiceal tumours.
Sarkar A; Lansom J; Dey A; Fisher O; Alzahrani N; Morris DL
Eur J Surg Oncol; 2021 Jun; 47(6):1406-1410. PubMed ID: 33279358
[TBL] [Abstract][Full Text] [Related]
60. Should a History of Extraperitoneal Disease Be a Contraindication to Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Colorectal Cancer Peritoneal Metastases?
Baratti D; Kusamura S; Iusco D; Cotsoglou C; Guaglio M; Battaglia L; Virzì S; Mazzaferro V; Deraco M
Dis Colon Rectum; 2018 Sep; 61(9):1026-1034. PubMed ID: 30086051
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
